Common pathogenic mechanisms in the hippocampus across neurodegenerative dementias: Alzheimer’s disease, Down syndrome, and Parkinson’s disease

Read full text
Authors: René A. J. Crans, Marta Fructuoso, Karen Bascon Cardozo, Hatice Recaioglu, José Honório de Almeida Palma da Fonseca, Yannick Vermeiren, André Strydom, Debby Van Dam, Peter Paul De Deyn, Bernardo Rodríguez-Martín, Marie‐Claude Potier, Mara Dierssen
Cited by: 0
References: 84

Abstract

Abstract Extensive evidence suggests overlapping pathological mechanisms in the brain of individuals with Parkinson´s disease dementia, Down syndrome dementia, and Alzheimer´s disease. For these neurodegenerative dementias, we observed that the chronological age did not align with their biological age, which was determined based on hippocampal transcript levels (i.e., transcriptional age). Subsequently, we performed a transcriptomic analysis that corrected for the transcriptional age in the hippocampus of affected individuals, highlighting common underlying pathogenic mechanisms. There were 45 common differentially expressed genes (DEGs), whereas enriched functional terms were related to lysine N-methyltransferase activity and intermediate filament. Co-expression network analysis displayed a module that was significantly downregulated in the non-demented control group only. This module identified EHMT2 and LMNB2 as hub genes, which were also common DEGs. Overall, these findings uncover shared functional insights in the hippocampus, while specifically highlighting EHMT2 and LMNB2 as potential universal biomarkers or disease-altered targets across neurodegenerative dementias.

Fields of Study & Subjects

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Neuroinflammation and Neurodegeneration Mechanisms

Publication details

Journal / source
npj Dementia
Publisher
Springer Science and Business Media LLC
Volume
2
Issue
1
Pages
32–32
Publication date
29 April 2026
Language
EN